Your browser doesn't support javascript.
How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care.
Bachmeier, Beatrice E; Hölzle, Salome; Gasser, Mohamed; van den Akker, Marjan.
  • Bachmeier BE; Institute of Pharmaceutical Biology, Goethe-University, 60438 Frankfurt am Main, Germany.
  • Hölzle S; Institute of Pharmaceutical Biology, Goethe-University, 60438 Frankfurt am Main, Germany.
  • Gasser M; Institute of Pharmaceutical Biology, Goethe-University, 60438 Frankfurt am Main, Germany.
  • van den Akker M; Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany.
Viruses ; 15(4)2023 04 20.
Article in English | MEDLINE | ID: covidwho-2291746
ABSTRACT

BACKGROUND:

Many patients with ongoing complaints after a SARS-CoV-2 infection are treated in primary care. Existing medical guidelines on how to diagnose and treat Long-/Post-COVID are far from being comprehensive. This study aims to describe how German general practitioners (GPs) deal with this situation, what problems they experience when managing such patients, and how they solve problems associated with the diagnosis and treatment of Long-/Post-COVID. METHODS AND

FINDINGS:

We conducted a qualitative study and interviewed 11 GPs. The most commonly described symptoms were ongoing fatigue, dyspnea, chest tightness and a decrease in physical capacity. The most common way to identify Long-/Post-COVID was by exclusion. Patients suffering from Long-/Post-COVID were generally treated by their GPs and rarely referred. A very common non-pharmacological intervention was to take a wait-and-see approach and grant sick leave. Other non-pharmacological interventions included lifestyle advices, physical exercise, acupuncture and exercises with intense aromas. Pharmacological treatments focused on symptoms, like respiratory symptoms or headaches. Our study's main limitations are the small sample size and therefore limited generalizability of results.

CONCLUSIONS:

Further research is required to develop and test pharmaceutical and non-pharmaceutical interventions for patients with Long-/Post-COVID. In addition, strategies to prevent the occurrence of Long-/Post-COVID after an acute infection with SARS-CoV-2 have to be developed. The routine collection of data on the diagnosis and management of Long-/Post-COVID may help in the formulation of best practices. It is up to policymakers to facilitate the necessary implementation of effective interventions in order to limit the huge societal consequences of large groups of patients suffering from Long-/Post-COVID.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: General Practitioners / COVID-19 Type of study: Diagnostic study / Experimental Studies / Qualitative research / Randomized controlled trials Topics: Long Covid / Traditional medicine Limits: Humans Language: English Year: 2023 Document Type: Article Affiliation country: V15041016

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: General Practitioners / COVID-19 Type of study: Diagnostic study / Experimental Studies / Qualitative research / Randomized controlled trials Topics: Long Covid / Traditional medicine Limits: Humans Language: English Year: 2023 Document Type: Article Affiliation country: V15041016